The Future of Anesthesia and Respiratory Devices, Competitive Landscape and Forecasts to 2016 - Home and Self Care Respiratory Devices Presenting Growth Avenues

Additional Information

The Future of Anesthesia and Respiratory Devices, Competitive Landscape and Forecasts to 2016 - Home and Self Care Respiratory Devices Presenting Growth Avenues

The Global Anesthesia and Respiratory Devices Market to Exceed $13 Billion by 2016

Anesthesia and Respiratory Devices, Global, Overall Revenues ($ billion), 2009 - 2016

Source: GBI Research

The global anesthesia and respiratory devices market is forecast to exceed $13 billion by 2016 with a Compound Annual Growth Rate (CAGR) of 9% from 2009-2016. The market is expected to be primarily driven by the huge patient population suffering from Obstructive Sleep Apnea (OSA) and Chronic Obstructive Pulmonary Disease (COPD) and the availability of medical devices to treat OSA and COPD. Globally about 300 million people are suffering from OSA, the prevalence of which increases with age, reaching 30% to 80% in the elderly population. Currently, about 400 to 600 million people are suffering from COPD on a global basis with about 12 million patients in the US.

Respiratory Devices to Remain the Largest Category in the Global Anesthesia and Respiratory Devices Market

Anesthesia and Respiratory Devices, Global, Category Contribution(%), 2009

Source: GBI Research

Respiratory devices accounted for 55% of the overall anesthesia and respiratory devices market in 2009, making it the largest category. This category is forecast to reach 59% of the overall market by 2016. The global market for respiratory devices was valued at $4.2 billion in 2009, and is forecast to grow at a CAGR of 10% to reach $8.2 billion in 2016. The market is expected to be driven by reimbursement approval by the US Centers for Medicare & Medicaid services for CPAP devices based on home diagnosis of OSA, the patient population suffering from OSA and COPD and the increasing demand for low priced portable oxygen concentrators.

Growth in Home Healthcare Equipment and the US Centers for Medicare and Medicaid Services (CMS) Expansion of Reimbursement for a Number of Sleep Tests for the Diagnosis of Obstructive Sleep Apnea to Boost Market Growth

The demand for respiratory devices is expected to increase following growth in the home healthcare market. Rising healthcare costs are leading to more people getting treated at home and this provides impetus for growth for respiratory devices such as Positive Airway Pressure (PAP) devices, nebulizers, humidifiers and oxygen concentrators. Also in the US, the Centers for Medicare and Medicaid Services (CMS) expansion of reimbursement coverage for home sleep tests for the diagnosis of OSA is expected to boost the home healthcare market. CMS's 2009 Physician Fee Schedule extends reimbursement coverage to diagnoses made with home sleep test systems, provided the provider of the home sleep test device does not also have a financial interest in selling devices used for OSA treatment. This reimbursement is expected to significantly increase the number of people diagnosed with OSA and undergoing OSA treatment.

The US to Continue to be the Biggest Market for Anesthesia and Respiratory Devices

Anesthesia and Respiratory Devices, Geographic Contribution (%), 2009

Source: GBI Research

The US is the biggest market for anesthesia and respiratory devices, contributing 49% towards the global market in 2009, and this contribution is expected to increase to 54% by 2016. The US market for anesthesia and respiratory devices was valued at $3.7 billion in 2009, and is forecast to grow at a CAGR of 10% to reach $7.4 billion in 2016. The US market is expected to be driven by those patients suffering from OSA (15 million) and COPD (12 million), the availability of reimbursement for anesthesia and respiratory devices and the growth in the home healthcare equipment market.

Increasing Investments in Healthcare Infrastructure to Drive Growth in Emerging Economies such as China

In 2009, the Chinese Government announced it was spending $125 billion in the healthcare sector over the next three years as part of its economic stimulus package. The spending includes expanding healthcare insurance coverage to 90% of the population. The money will also be spent on constructing 30,000 hospitals, clinics, and care centers and upgrading existing healthcare facilities. Annual healthcare subsidies under the latest healthcare reforms will increase to $18 per person from the current $12 per person. In China, there is a growing demand for quality medical devices among the general population bolstered by higher income levels. This is providing an impetus for significant investment in the healthcare sector by the government.

Anestheisa and Respiratory Devices, Global, Company Share (%), 2009

Source: GBI Research

In 2009, Draegerwerk AG & Co. KGaA, Covidien, GE Healthcare and Philips Respironics were the leading players in the anesthesia and respiratory devices market with a combined market share of 42%. Draegerwerk AG & Co. KGaA and GE Healthcare dominate the anesthesia machines market. Philips Respironics is one of the leading players in the respiratory devices market and Covidien is the market leader in the respiratory measurement devices market. The reasons why these companies dominate is attributed to their long term presence in the healthcare market, the relationships they have developed with hospitals and physicians over a period of time and the brand name they enjoy with patients.